Team:AITM-Nepal

From 2013.igem.org

(Difference between revisions)
Line 1: Line 1:
<html>
<html>
<head>
<head>
-
        <style>
+
<style>
-
#catlinks,#top-section,#footer-box,#top
+
#catlinks,#top-section,#footer-box,#top,#p-logo
{
{
-
display:none;
+
display:none;
}
}
-
      body{
+
body
-
          background-image:url('https://static.igem.org/mediawiki/2013/7/76/Back.jpg');
+
-
          background-attachment:fixed;
+
-
          background-size:100%;
+
-
          }
+
-
 
+
-
 
+
-
#p-logo
+
{
{
-
display:none;
+
background-image:url('https://static.igem.org/mediawiki/2013/7/76/Back.jpg');
 +
background-attachment:fixed;
 +
background-size:100%;
}
}
 +
#content
#content
{
{
background:#aaaaaa;
background:#aaaaaa;
 +
width:auto;
}
}
-
#access{
+
.navbar
-
background: linear-gradient(#252525, #0A0A0A) repeat scroll 0 0 transparent;
+
{
-
    box-shadow: 0 1px 2px rgba(0, 0, 0, 0.4);
+
margin-top:20px;
-
    clear: both;
+
list-style:none;
-
    display: block;
+
border-top:1px #000000 ;
-
    float: left;
+
border-bottom:1px #000000;
-
    margin: auto;
+
border-bottom-left-radius:40px;
-
    margin-bottom:10px;
+
border-top-left-radius:40px;
-
    width: 100%;
+
border-left:#000 1px solid;
-
overflow:hidden;
+
border-bottom-right-radius:40px;
-
}
+
border-top-right-radius:40px;
-
+
border-right:#000 1px ;
-
+
padding-left:10px;
-
#access ul {
+
padding-top:20px;
-
    font-size: 13px;
+
padding-bottom:10px;
-
    list-style: none outside none;
+
width: 1110px;
-
   
+
background:rgba(153,153,153,0.6);
-
    padding-left: 0;
+
color:#666;
-
}
+
margin:auto;
-
+
}
-
#access li {
+
-
    float: left;
+
-
    margin-left:5px;
+
-
    position: relative;
+
-
    list-style:none;
+
-
}
+
-
+
-
#access a{
+
-
color: #EEEEEE;
+
-
    display: block;
+
-
    line-height: 3.333em;
+
-
    Padding-left:9px;
+
-
    padding-right:9px;
+
-
    text-decoration: none;
+
-
}
+
-
+
-
#access li:hover > a{
+
-
background: #efefef;
+
-
background: #f9f9f9; /* Show a solid color for older browsers */
+
-
background: -moz-linear-gradient(#f9f9f9, #e5e5e5);
+
-
background: -o-linear-gradient(#f9f9f9, #e5e5e5);
+
-
background: -webkit-gradient(linear, 0% 0%, 0% 100%, from(#f9f9f9), to(#e5e5e5)); /* Older webkit syntax */
+
-
background: -webkit-linear-gradient(#f9f9f9, #e5e5e5);
+
-
color: #373737;
+
-
}
+
-
+
 +
.navbar .firstLi
 +
{
 +
margin-left:20px;
 +
}
-
#headerbar
+
 
 +
.navbar li
{
{
-
width:975;
+
display:inline;
-
height:150px;
+
padding-right:5px;
-
margin-bottom:15px;
+
padding-top:20px;
-
margin:auto;
+
padding-bottom:10px;
-
padding-left:10px;
+
margin-left:0px;
 +
margin-right:0px;
 +
padding:15px;
 +
}
 +
 
 +
.navbar li a
 +
{
 +
color:#666;
 +
}
 +
 
 +
.navbar li:hover
 +
{
 +
background:#0CC;
 +
-webkit-transition: padding 2s, background 2s;
 +
-moz-transition:padding 2s, background 2s;
}
}
Line 90: Line 80:
}
}
-
#bodyContent
+
#box
-
              {
+
-
              width:1000px;
+
-
              float:left;
+
-
              }
+
-
#mainbox
+
{
{
-
background:rgba(66, 125, 118, 0.8);
+
overflow:hidden;
-
padding:20px;
+
text-align:center;
-
margin-top:50px;
+
background-color:#2d2d2d;  
-
border-radius:50px;
+
height:400px;  
 +
width:900px;
 +
margin:auto;
 +
border-bottom:30px #666666 groove;
 +
border-bottom-left-radius:20px;
 +
border-bottom-right-radius:20px;
 +
border-top:30px #666666 groove;
 +
border-top-left-radius:20px;
 +
border-top-right-radius:20px;
 +
margin-top:20px;
}
}
 +
#smallbox1
#smallbox1
{
{
-
position:absolute; margin-top:180px; float:left; padding:20px; background:black; opacity:0.5;
+
position:absolute;
 +
margin-top:180px;  
 +
float:left;  
 +
padding:20px;  
 +
background:black;  
 +
opacity:0.5;
}
}
#smallbox2
#smallbox2
{
{
-
position:absolute; margin-top:180px; margin-left:911px; padding:20px; background:black; opacity:0.5;
+
position:absolute;
 +
margin-top:180px;
 +
margin-left:850px;
 +
padding:20px;
 +
background:black;
 +
opacity:0.5;
 +
}
}
#smallbox1:hover
#smallbox1:hover
{
{
-
opacity:0.8;
+
opacity:0.8;
}
}
#smallbox2:hover
#smallbox2:hover
{
{
-
opacity:0.8;
+
opacity:0.8;
}
}
 +
 +
#logo
 +
{
 +
width:150px;
 +
height:150px;
 +
margin-right:100px;
 +
}
 +
 +
#logo2
 +
{
 +
float:right;
 +
width:200px;
 +
height:150px;
 +
}
 +
</style>
</style>
Line 176: Line 197:
<script src="http://code.jquery.com/jquery-1.10.2.js"></script>
<script src="http://code.jquery.com/jquery-1.10.2.js"></script>
 +
                 
 +
<img id="logo" src="https://static.igem.org/mediawiki/2013/d/d1/Hava1.png">
 +
<a href="https://2013.igem.org/Main_Page"><img id="logo2" src="https://static.igem.org/mediawiki/2013/e/e3/Wiki1.png"></a>
-
                  <div id="mainbox">
 
-
 
-
                  <div id="headerbar">
 
-
<img src="https://static.igem.org/mediawiki/2013/d/d1/Hava1.png" height="145px' style="float:left;">
 
-
<a href="https://2013.igem.org/Main_Page"><img src="https://static.igem.org/mediawiki/2013/e/e3/Wiki1.png" style="float:right;" height="120px"></a>
 
-
 
-
                  </div>
 
 +
<ul class="navbar">
 +
<li>
 +
<a href="https://2013.igem.org/Team:AITM-Nepal">Home</a>
 +
</li>
 +
<li>
 +
<a href="https://2013.igem.org/Team:AITM-Nepal/Team">Team</a>
 +
</li>
 +
                        <li>
 +
<a href="https://igem.org/Team.cgi?year=2013&team_name=AITM-Nepal">Official Team Profile</a>
 +
</li>
 +
                        <li>
 +
<a href="https://2013.igem.org/Team:AITM-Nepal/Project">Project</a>
 +
</li>
 +
<li>
 +
<a href="https://2013.igem.org/Team:AITM-Nepal/Parts">Parts Submitted To Registry</a>
 +
</li>
 +
                        <li>
 +
<a href="https://2013.igem.org/Team:AITM-Nepal/Modeling">Modeling</a>
 +
</li>
 +
                        <li>
 +
<a href="https://2013.igem.org/Team:AITM-Nepal/Notebook">Notebook</a>
 +
</li>
 +
<li>
 +
<a href="https://2013.igem.org/Team:AITM-Nepal/Safety">Safety</a>
 +
</li>
 +
                        <li> 
 +
                                <a href="https://2013.igem.org/Team:AITM-Nepal/Human_practise">Human Practice</a>
 +
                        </li>
 +
                        <li>
 +
<a href="https://2013.igem.org/Team:AITM-Nepal/Attributions">Attributions</a>
 +
</li>
 +
</ul>
-
                    <div style="margin-bottom:10px;">
 
-
<font size=6px color="white">Welcome to Team AITM_Nepal's Wiki!</font><br>
 
-
                    </div>
+
                   
Line 227: Line 274:
                                
                                
-
                                         <div id="box" style="overflow:hidden; text-align:center; background-color:#2d2d2d; height:400px;">
+
                                         <div id="box">
<div id="smallbox1"><font color="white"><a href="" onClick="prev();"><</a></font></div>
<div id="smallbox1"><font color="white"><a href="" onClick="prev();"><</a></font></div>
Line 234: Line 281:
                                         </div>
                                         </div>
 +
 +
<br/>
-
 
+
                                    <div style="margin:auto; width:1000px; color:#555;" >
-
 
+
<font size=6px color="white">Welcome to Team AITM_Nepal's Wiki!</font><br><br>
-
        <nav id="access">
+
-
<div class="menu">
+
-
<ul>
+
-
<li>
+
-
<a href="https://2013.igem.org/Team:AITM-Nepal">Home</a>
+
-
</li>
+
-
<li>
+
-
<a href="https://2013.igem.org/Team:AITM-Nepal/Team">Team</a>
+
-
</li>
+
-
                        <li>
+
-
<a href="https://igem.org/Team.cgi?year=2013&team_name=AITM-Nepal">Official Team Profile</a>
+
-
</li>
+
-
                        <li>
+
-
<a href="https://2013.igem.org/Team:AITM-Nepal/Project">Project</a>
+
-
</li>
+
-
<li>
+
-
<a href="https://2013.igem.org/Team:AITM-Nepal/Parts">Parts Submitted To Registry</a>
+
-
</li>
+
-
                        <li>
+
-
<a href="https://2013.igem.org/Team:AITM-Nepal/Modeling">Modeling</a>
+
-
</li>
+
-
                        <li>
+
-
<a href="https://2013.igem.org/Team:AITM-Nepal/Notebook">Notebook</a>
+
-
</li>
+
-
<li>
+
-
<a href="https://2013.igem.org/Team:AITM-Nepal/Safety">Safety</a>
+
-
</li>
+
-
                        <li> 
+
-
                                <a href="https://2013.igem.org/Team:AITM-Nepal/Human_practise">Human Practice</a>
+
-
                        </li>
+
-
                        <li>
+
-
<a href="https://2013.igem.org/Team:AITM-Nepal/Attributions">Attributions</a>
+
-
</li>
+
-
</ul>
+
-
</div>
+
-
</nav>
+
-
 
+
-
<br/>
+
-
                                    <div style="padding:'auto'; margin:10px;">
+
<h2><b><font color="white">Our Project:</font></b></h2>
<h2><b><font color="white">Our Project:</font></b></h2>
-
<h3><b><font color="white">ImmunEcoli</font></b></h3>
+
<h3><b><ImmunEcoli</font></b></h3>
<font color="white">This is the first approach for Synthetic Biology from Nepal. We are a team of Undergrads of Biotechnology from Asian Institute of Technology and Management. This year we are trying to engineer ''Escherichia coli'' which will be used as a carrier and immune modulation point using Outer Membrane Vesicle (OMVs). ''Escherichia coli'', being a model organism, is easier to work with , especially for the purpose of genetically engineered realm.
<font color="white">This is the first approach for Synthetic Biology from Nepal. We are a team of Undergrads of Biotechnology from Asian Institute of Technology and Management. This year we are trying to engineer ''Escherichia coli'' which will be used as a carrier and immune modulation point using Outer Membrane Vesicle (OMVs). ''Escherichia coli'', being a model organism, is easier to work with , especially for the purpose of genetically engineered realm.
Line 289: Line 299:
Canonical small interfering RNA (siRNA) duplexes are potent activators of the mammalian innate immune system. The induction of innate immunity by siRNA is dependent on siRNA structure and sequence, method of delivery, and cell type. The delivery of siRNA in a packaged outer membrane vesicle of gram negative bacteria is the theme of our work. The toll like receptor-7/8 activation by siRNA in order to boost the production of Interferon type -1 molecules to inhibit the viral and outer membrane LPS structure to activate Toll like receptor -4 to inhibit bacterial pathogens is the objective of this work. The delivery is made dependent on the peptide fragment which mediated the fusogenic mechanism so as to escape the endosomal compartment once endocytosed inside host(mamalian) cell. Thus freeing the siRNA to silence the myD88 transcript in host cytoplasm making RISC complex and hence, activating TLR-7/8 in endosomal membrane formerly.
Canonical small interfering RNA (siRNA) duplexes are potent activators of the mammalian innate immune system. The induction of innate immunity by siRNA is dependent on siRNA structure and sequence, method of delivery, and cell type. The delivery of siRNA in a packaged outer membrane vesicle of gram negative bacteria is the theme of our work. The toll like receptor-7/8 activation by siRNA in order to boost the production of Interferon type -1 molecules to inhibit the viral and outer membrane LPS structure to activate Toll like receptor -4 to inhibit bacterial pathogens is the objective of this work. The delivery is made dependent on the peptide fragment which mediated the fusogenic mechanism so as to escape the endosomal compartment once endocytosed inside host(mamalian) cell. Thus freeing the siRNA to silence the myD88 transcript in host cytoplasm making RISC complex and hence, activating TLR-7/8 in endosomal membrane formerly.
Contact us: aitmnepal2013@gmail.com
Contact us: aitmnepal2013@gmail.com
-
</font>
+
 
                                       </div>
                                       </div>
-
</div>
 

Revision as of 13:14, 8 September 2013


Welcome to Team AITM_Nepal's Wiki!

Our Project:

This is the first approach for Synthetic Biology from Nepal. We are a team of Undergrads of Biotechnology from Asian Institute of Technology and Management. This year we are trying to engineer ''Escherichia coli'' which will be used as a carrier and immune modulation point using Outer Membrane Vesicle (OMVs). ''Escherichia coli'', being a model organism, is easier to work with , especially for the purpose of genetically engineered realm. Canonical small interfering RNA (siRNA) duplexes are potent activators of the mammalian innate immune system. The induction of innate immunity by siRNA is dependent on siRNA structure and sequence, method of delivery, and cell type. The delivery of siRNA in a packaged outer membrane vesicle of gram negative bacteria is the theme of our work. The toll like receptor-7/8 activation by siRNA in order to boost the production of Interferon type -1 molecules to inhibit the viral and outer membrane LPS structure to activate Toll like receptor -4 to inhibit bacterial pathogens is the objective of this work. The delivery is made dependent on the peptide fragment which mediated the fusogenic mechanism so as to escape the endosomal compartment once endocytosed inside host(mamalian) cell. Thus freeing the siRNA to silence the myD88 transcript in host cytoplasm making RISC complex and hence, activating TLR-7/8 in endosomal membrane formerly. Contact us: aitmnepal2013@gmail.com

Retrieved from "http://2013.igem.org/Team:AITM-Nepal"